Actively Recruiting
The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
Led by NYU Langone Health · Updated on 2026-04-03
215
Participants Needed
1
Research Sites
81 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.
CONDITIONS
Official Title
The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients are candidates for elective primary total knee arthroplasty for a diagnosis of osteoarthritis or inflammatory arthritis
- Patients have been medically cleared and scheduled for surgery
You will not qualify if you...
- Patients with cold-related conditions such as cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, or Raynaud's disease
- Surgery planned for fracture, infection, or malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
D
Daniel Waren
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here